5-Lipoxygenase activating protein and leukotriene C4 synthase: therapeutic targets for inhibiting the leukotriene cascade.
Ford-Hutchinson
A W
AW
Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Quebec, Canada.
D058927:5-Lipoxygenase-Activating Proteins; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D005982:Glutathione Transferase / Q000037:antagonists & inhibitors*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007249:Inflammation / Q000188:drug therapy; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000096:biosynthesis; D008565:Membrane Proteins / Q000378:metabolism
D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D002352:Carrier Proteins; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D008565:Membrane Proteins; D005982:Glutathione Transferase; C041116:leukotriene-C4 synthase